Case number 1:20-cv-00962
Cephalon, Inc. v. Aurobindo Pharma, Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 3, 2020 | 8 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s); see report for numbers. (Attachments: # (1) Notice)(fms) |
| Aug 3, 2020 | 8 | Notice (2) |
| Jul 31, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per [7]. (fms) |
| Jul 31, 2020 | 7 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal as to All Defendants by Cephalon, Inc.. (Shaw, John) |
| Jul 22, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Jul 20, 2020 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (mal) |
| Jul 17, 2020 | 1 | Exhibit 1 (26) |
| Jul 17, 2020 | 1 | Exhibit 2 (28) |
| Jul 17, 2020 | 1 | Exhibit 3 (29) |
| Jul 17, 2020 | 1 | Exhibit 4 (28) |
| Jul 17, 2020 | 1 | Civil Cover Sheet (1) |
| Jul 17, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Jul 17, 2020 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: see attached. Date of Expiration of Patent: see attached. Thirty Month Stay Deadline: see attached. (mal) (Main Document 3 replaced on 7/21/2020) (amf). |
| Jul 17, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,436,190 B2 ;US 8,609,863 B2 ;US 8,791,270 B2 ;US 8,895,756 B2. (mal) (Main Document 4 replaced on 7/21/2020) (amf). |
| Jul 17, 2020 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Cephalon, Inc. filed by Cephalon, Inc.. (mal) |
